260129 - Contract for Supply, Delivery and Installation of Peptide Synthesizer and associated Maintenance, training, Ancillary Items and Consumables
No value published
This is a contract result notice, not an open opportunity. Details from the official award data.
The procurement contact named on the official notice.
Queen’s University Belfast - The Future Medicines Institute (FMI) intends to procure a peptide synthesis solution comprising equipment, associated consumables, and appropriate maintenance and support arrangements to enable in house peptide synthesis capability. • Establishment of a reliable, in house peptide synthesis capability aligned to research delivery requirements. • Provision of supplier support, including training, to ensure competent and effective operation by authorised users. • Delivery of scalable synthesis capability to support routine generation of short peptides and time efficient synthesis of longer peptide sequences. • Enablement of consistent, reproducible outputs to meet ongoing and future research needs.
The Future Medicines Institute (FMI) is focused on the identification and development of novel therapeutics and diagnostic approaches.
The required capability will support experimental workflows by enabling the generation of peptide materials essential to underpin these research activities, contributing to institutional strategic objectives in advanced therapeutics.
The solution is expected to support broader academic use, enabling access across relevant research groups and maximising utilisation.
This will facilitate collaborative research activity and enhance overall institutional research capability and impact.
What the notice asks for
Provision of supplier support, including training,
Provision of supplier support, including training, to ensure competent and effective operation by authorised users.
Delivery of scalable synthesis capability to support
Delivery of scalable synthesis capability to support routine generation of short peptides and time efficient synthesis of longer peptide sequences.
The required capability will support experimental workflows
The required capability will support experimental workflows by enabling the generation of peptide materials essential to underpin these research activities, contributing to institutional strategic objectives in advanced therapeutics.
The solution is expected to support broader
The solution is expected to support broader academic use, enabling access across relevant research groups and maximising utilisation.
Sentences from the notice that state an obligation, surfaced automatically and shown in the order they appear. Not an exhaustive list — always confirm against the tender documents.
Make the case to bid
Reveal who to approach at Queen's University Belfast, and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
- OCID
- ocds-h6vhtk-06a023
- Stage
- award · Awarded
- Source
- Find a Tender
- Buyer ref
- 086893-2026
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Musical, Sports & Leisure Goods
Queen's University Belfast’s tender network